An 87‑year‑old patient with chronic dizziness treated with betahistine (Betaserc), taking apixaban and silodosin for benign prostatic hyperplasia, also has stomach acidity and excessive gas. What could be causing the dizziness and how can it be relieved?

Dizziness in an 87-Year-Old: Silodosin is the Most Likely Culprit

The most probable cause of this patient's dizziness is silodosin-induced orthostatic hypotension, and the medication should be discontinued or dose-reduced immediately. 1

Primary Cause: Silodosin-Related Orthostatic Effects

Silodosin carries an FDA black-box warning for orthostatic hypotension with or without symptoms (including dizziness), particularly when initiating therapy 1. In an 87-year-old patient, this risk is substantially amplified. The drug label explicitly states that "postural hypotension, with or without symptoms (e.g., dizziness) may develop" and warns about potential syncope 1.

Key clinical consideration: While clinical trials showed similar dizziness rates between silodosin (2.9%) and placebo groups, elderly patients are at disproportionately higher risk due to age-related cardiovascular changes and polypharmacy 2, 3.

Secondary Concern: Apixaban Interaction

The combination of silodosin (an alpha-blocker) with apixaban creates additive vasodilatory effects. Although the FDA label notes that Phase 3 studies didn't show significantly increased syncope or orthostasis with concomitant antihypertensives, it explicitly advises to "exercise caution during concomitant use" and "monitor patients for possible adverse events" 1. At 87 years old, this patient's cardiovascular reserve is limited, making him particularly vulnerable to these combined effects.

The Gastrointestinal Connection

The patient's complaint that "gases are increasing the dizziness" suggests vasovagal-mediated symptoms. Gastric distension from excessive gas can trigger vagal responses that exacerbate orthostatic intolerance, particularly in elderly patients already compromised by alpha-blocker therapy. The stomach acidity may also indicate GERD, which can worsen this vagal stimulation.

Differential Considerations (Less Likely but Important)

Benign Paroxysmal Positional Vertigo (BPPV)

BPPV is the most common cause of vertigo in elderly patients 4. However, BPPV causes brief (seconds-long) episodes of spinning triggered by specific head positions, not chronic continuous dizziness 5, 4. The patient's chronic presentation makes this less likely as the primary etiology.

Betahistine-Related Effects

While betahistine is prescribed for the dizziness, a rare case report documents betahistine-associated neuropsychiatric effects including depression 6. However, this patient lacks psychiatric symptoms, and betahistine generally improves rather than causes dizziness in most patients 7.

Age-Related Multifactorial Dizziness

At 87, polyneuropathy, bilateral vestibulopathy, and polypharmacy are common contributors 8. However, these typically cause chronic baseline dizziness rather than acute worsening.

Management Algorithm

Immediate Actions (Priority Order):

1. Discontinue or reduce silodosin dose

   • If BPH symptoms are mild-moderate: Stop silodosin entirely
   • If BPH symptoms are severe: Reduce to 4 mg daily (the dose recommended for renal impairment, which is common at age 87) 1
   • Monitor for symptom improvement within 48-72 hours

2. Assess renal function

   • Silodosin levels increase 3-fold in moderate renal impairment (CrCl 30-50 mL/min), doubling the half-life 1
   • If CrCl <30 mL/min, silodosin is contraindicated 1
   • Many 87-year-olds have unrecognized renal impairment

3. Evaluate orthostatic vital signs

   • Measure blood pressure supine and after 1-3 minutes standing
   • A drop of ≥20 mmHg systolic or ≥10 mmHg diastolic confirms orthostatic hypotension
   • This confirms silodosin as the culprit

4. Address gastrointestinal symptoms

   • Treat stomach acidity with a proton pump inhibitor or H2-blocker
   • Reduce gas with simethicone and dietary modifications (avoid carbonated beverages, gas-producing foods)
   • This may provide 20-30% symptom relief by reducing vagal triggers

If Dizziness Persists After Silodosin Adjustment:

1. Perform Dix-Hallpike maneuver

   • Rule out BPPV, which can coexist with medication-related dizziness 4
   • If positive, perform Epley maneuver (80% success rate) 4

2. Review betahistine efficacy

   • If dizziness persists despite 12+ weeks of betahistine, consider discontinuation
   • Betahistine shows 66% improvement rates in chronic dizziness, meaning 34% don't respond 7

3. Consider vestibular rehabilitation

   • Particularly beneficial in elderly patients with multifactorial dizziness 8

Critical Pitfalls to Avoid

• Don't assume betahistine is working just because it's prescribed – chronic dizziness despite ongoing betahistine suggests either wrong diagnosis or treatment failure
• Don't overlook renal function – age-related decline may cause toxic silodosin levels even at standard doses
• Don't continue silodosin "because BPH needs treatment" – alternative BPH therapies (5-alpha reductase inhibitors, anticholinergics, beta-3 agonists) don't cause orthostatic hypotension 9
• Don't dismiss the GI symptoms as unrelated – vagal mechanisms directly link gastric distension to dizziness in elderly patients

The most straightforward intervention with highest likelihood of success: Stop or reduce silodosin and reassess in 3 days. If dizziness resolves, this confirms the diagnosis. If BPH symptoms become problematic, switch to a 5-alpha reductase inhibitor (finasteride/dutasteride) which lacks cardiovascular effects 9.